Development of a highly sensitive chemiluminescence immunoassay using a novel signal-enhanced detection system for quantitation of durvalumab, an immune-checkpoint inhibitor monoclonal antibody used for immunotherapy of lung cancer

Durvalumab (DUR) is a human monoclonal antibody used for the immunotherapy of lung cancer. It is a novel immune-checkpoint inhibitor, which blocks the programmed death 1 (PD-1) and programmed death-ligand 1 (PD-L1) proteins and works to promote the normal immune responses that attack the tumour cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Darwish, Ibrahim A., Alzoman, Nourah Z., Khalil, Nehal N.Y., Darwish, Hany W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300215/
https://www.ncbi.nlm.nih.gov/pubmed/37389074
http://dx.doi.org/10.1016/j.heliyon.2023.e15782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300215/
https://www.ncbi.nlm.nih.gov/pubmed/37389074
http://dx.doi.org/10.1016/j.heliyon.2023.e15782

Ejemplares similares